Reply to Tuomas Mirtti and Tero Aittokallio's Letter to the Editor re: Fatemeh Seyednasrollah, Mehrad Mahmoudian, Liisa Rautakorpi, et al. How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer? Eur Urol. 2017;71:838-40. Clinical Utility of Trial-estimated Prognostic Models. [electronic resource]

By: Contributor(s): Producer: 20180522Description: e70-e71 p. digitalISSN:
  • 1873-7560
Subject(s): Online resources: In: European urology vol. 72
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Letter; Research Support, Non-U.S. Gov't; Comment

There are no comments on this title.

to post a comment.